ARCHIVES

DCT Board Delays Action On Protein Index, Refuses Support for Cow Study, Approves Various Concepts

This article is from The Cancer Letter archive.

Vol. 07 No. 42 | October 16, 1981

Download PDF Visit The Full Archive

Related Articles

Challoner: We Recommended FDA Replace 510(k) Clearance

July 4, 2014

NCAB: An Extraordinary Opportunity For Budgetary Coordination.

February 25, 2000

FDA Ponders Standards For “Retrospective Prospective” Studies

January 30, 2009

December Business & Regulatory Report included in this issue.

December 12, 2003

In Brief: NCI Would Get Extra $115 Million Over Three Years Under Budget Amendment By Alabama Senator

June 4, 1982

NCI Announces New CREG Offer For In Vitro Chemical Carcinogenesis Tests

November 21, 1975